Filters
| Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
|---|---|---|---|
Institute for Genomic Medicine (IGM) Clinical Laboratory Nationwide Children's Hospital United States | 9 | 14 |
|
Cardiology Sequencing- Congenital heart Disease Panel (24 Genes) Genesys Diagnostics Genesys Diagnostics, Inc. United States | 24 | 24 |
|
Cardiology Sequencing- Arrhythmia Comprehensive Panel (134 Genes) Genesys Diagnostics Genesys Diagnostics, Inc. United States | 88 | 134 |
|
Cardiology Sequencing- Full Panel (174 Genes) Genesys Diagnostics Genesys Diagnostics, Inc. United States | 122 | 174 |
|
Health in Code Spain | 26 | 12 |
|
Clinical Genomics Unit Hospital Universitari Germans Trias i Pujol Spain | 5 | 16 |
|
Clinical Genomics Unit Hospital Universitari Germans Trias i Pujol Spain | 9 | 19 |
|
Centogene US, LLC - The Rare Disease Company United States | 289 | 275 |
|
Centogene US, LLC - The Rare Disease Company United States | 740 | 728 |
|
Centogene US, LLC - The Rare Disease Company United States | 829 | 848 |
|
Centogene US, LLC - The Rare Disease Company United States | 1886 | 1858 |
|
SHOC2 - NGS including CNV analysis Centogene US, LLC - The Rare Disease Company United States | 1 | 1 |
|
SHOC2 - NGS including CNV analysis Centogene AG - the Rare Disease Company Germany | 1 | 1 |
|
Centogene AG - the Rare Disease Company Germany | 1886 | 1858 |
|
Centogene AG - the Rare Disease Company Germany | 289 | 275 |
|
Centogene AG - the Rare Disease Company Germany | 740 | 728 |
|
Centogene AG - the Rare Disease Company Germany | 829 | 848 |
|
Invitae Leukodystrophy and Genetic Leukoencephalopathy Panel Invitae United States | 971 | 680 |
|
Invitae RASopathies and Noonan Spectrum Disorders Panel Invitae United States | 60 | 28 |
|
Invitae Neurodevelopmental Disorders Panel Invitae United States | 404 | 241 |
|
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.